Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Proc Natl Acad Sci U S A ; 106(8): 2537-42, 2009 Feb 24.
Artigo em Inglês | MEDLINE | ID: mdl-19196988

RESUMO

Plasmodium falciparum parasites are responsible for the major global disease malaria, which results in >2 million deaths each year. With the rise of drug-resistant malarial parasites, novel drug targets and lead compounds are urgently required for the development of new therapeutic strategies. Here, we address this important problem by targeting the malarial neutral aminopeptidases that are involved in the terminal stages of hemoglobin digestion and essential for the provision of amino acids used for parasite growth and development within the erythrocyte. We characterize the structure and substrate specificity of one such aminopeptidase, PfA-M1, a validated drug target. The X-ray crystal structure of PfA-M1 alone and in complex with the generic inhibitor, bestatin, and a phosphinate dipeptide analogue with potent in vitro and in vivo antimalarial activity, hPheP[CH(2)]Phe, reveals features within the protease active site that are critical to its function as an aminopeptidase and can be exploited for drug development. These results set the groundwork for the development of antimalarial therapeutics that target the neutral aminopeptidases of the parasite.


Assuntos
Antígenos CD13/antagonistas & inibidores , Inibidores Enzimáticos/farmacologia , Plasmodium falciparum/enzimologia , Animais , Antígenos CD13/química , Antígenos CD13/metabolismo , Cromatografia Líquida de Alta Pressão , Cristalografia por Raios X , Desenho de Fármacos , Eletroforese em Gel de Poliacrilamida , Inibidores Enzimáticos/química , Modelos Moleculares , Conformação Proteica , Especificidade por Substrato
2.
Acta Crystallogr D Biol Crystallogr ; D64(Pt 7): 810-4, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18566516

RESUMO

There is a pressing need for the archiving and curation of raw X-ray diffraction data. This information is critical for validation, methods development and improvement of archived structures. However, the relatively large size of these data sets has presented challenges for storage in a single worldwide repository such as the Protein Data Bank archive. This problem can be avoided by using a federated approach, where each institution utilizes its institutional repository for storage, with a discovery service overlaid. Institutional repositories are relatively stable and adequately funded, ensuring persistence. Here, a simple repository solution is described, utilizing Fedora open-source database software and data-annotation and deposition tools that can be deployed at any site cheaply and easily. Data sets and associated metadata from federated repositories are given a unique and persistent handle, providing a simple mechanism for search and retrieval via web interfaces. In addition to ensuring that valuable data is not lost, the provision of raw data has several uses for the crystallographic community. Most importantly, structure determination can only be truly repeated or verified when the raw data are available. Moreover, the availability of raw data is extremely useful for the development of improved methods of image analysis and data processing.


Assuntos
Bases de Dados Factuais , Software , Difração de Raios X , Academias e Institutos , Cristalografia por Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...